Myeloproliferative neoplasm (MPN) is a chronic hematologic malignancy characterized by chronic inflammation [7–9], high TNFα levels in serum [10], activation of NFĸB [11] and reduced expression of XIAP [12]. This evidence concerns the gene TNF and myeloproliferative disorder.